Leonard Calabrese physician and researcher
Calabrese, Leonard
VIAF ID: 4034439 (Personal)
Permalink: http://viaf.org/viaf/4034439
Preferred Forms
- 100 1 _ ‡a Calabrese, Leonard
- 100 1 _ ‡a Calabrese, Leonard
- 100 0 _ ‡a Leonard Calabrese ‡c physician and researcher
4xx's: Alternate Name Forms (1)
Works
Title | Sources |
---|---|
The A, B, Cs of viral hepatitis in the biologic era. | |
AIDS epidemic [VR] c1987: | |
The American College of Rheumatology 1990 criteria for the classification of Wegener's granulomatosis | |
Anakinra treatment of patients with rheumatoid arthritis | |
CD8 T-Cell Expansion and Inflammation Linked to CMV Coinfection in ART-treated HIV Infection | |
Chronic inflammatory arthritis following checkpoint inhibitor therapy for cancer: game changing implications | |
Cryoglobulinemic vasculitis and lymphocytic interstitial pneumonitis in a person with HIV infection | |
The effects of rituximab on immunocompetency in patients with autoimmune disease | |
EULAR points to consider for the diagnosis and management of rheumatic immune-related adverse events due to cancer immunotherapy with checkpoint inhibitors | |
The frequency of low muscle mass and its overlap with low bone mineral density and lipodystrophy in individuals with HIV--a pilot study using DXA total body composition analysis. | |
HIV update 2002: delaying treatment to curb rising resistance. | |
HIV update 2005: origins, issues, prospects, and complications | |
Immunologic failure despite suppressive antiretroviral therapy is related to activation and turnover of memory CD4 cells | |
Induction of clinical autoimmune disease by therapeutic interferon-alpha | |
Inflammation Perturbs the IL-7 Axis, Promoting Senescence and Exhaustion that Broadly Characterize Immune Failure in Treated HIV Infection | |
L36. Evidence-based clinical science and art in the diagnosis of central nervous system vasculitis | |
Lupus-related hepatitis: complication of lupus or autoimmune association? Case report and review of the literature | |
Management of rheumatic disease with comorbid HBV or HCV infection. | |
Narrative review: reversible cerebral vasoconstriction syndromes | |
Neutrophilic myositis: an extra-intestinal manifestation of ulcerative colitis. | |
The pathophysiology of HCV induced B-cell clonal disorders | |
Pilot study of coronary atherosclerotic risk and plaque burden in HIV patients: 'a call for cardiovascular prevention'. | |
Primary angiitis of the CNS. | |
Proceedings of the 2013 Rheumatology Winter Clinical Symposia | |
Progressive multifocal leukoencephalopathy in rheumatic diseases: evolving clinical and pathologic patterns of disease | |
Recent advances in vascular inflammation: C-reactive protein and other inflammatory biomarkers | |
Rheumatic diseases and syndromes induced by cancer immunotherapy, 2021: | |
Rheumatic manifestations of hepatitis C infection | |
Risks of immunosuppressive therapies including biologic agents in patients with rheumatic diseases and co-existing chronic viral infections. | |
Role of Natural Autoantibodies in Ugandans With Rheumatic Heart Disease and HIV. | |
SARS CoV-2 infection among patients using immunomodulatory therapies | |
SIV/SHIV Infection Triggers Vascular Inflammation, Diminished Expression of Krüppel-like Factor 2 and Endothelial Dysfunction. | |
Tumor necrosis factor inhibitors and lung disease: a paradox of efficacy and risk | |
Viral hepatitis: review of arthritic complications and therapy for arthritis in the presence of active HBV/HCV. | |
Virally associated arthritis 2008: clinical, epidemiologic, and pathophysiologic considerations |